{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:46:16Z","timestamp":1762508776014,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejso.2022.06.022","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T11:53:34Z","timestamp":1655726014000},"page":"2159-2165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study"],"prefix":"10.1016","volume":"48","author":[{"given":"Yuqian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.06.022_bib1","first-page":"363","article-title":"Cancer treatment and survivorship statistics","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2022.06.022_bib2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \"silver tsunami\": prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejso.2022.06.022_bib3","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1200\/JCO.2005.01.230","article-title":"Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer","volume":"23","author":"Demark-Wahnefried","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib4","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.30164","article-title":"Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008","volume":"122","author":"Donin","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.06.022_bib5","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.14694\/EdBook_AM.2014.34.e57","article-title":"The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults","author":"Morton","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejso.2022.06.022_bib6","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2020.23130","article-title":"Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States","volume":"324","author":"Sung","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2022.06.022_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2022.06.022_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114012","article-title":"Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2022.06.022_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","article-title":"Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035","volume":"69","author":"Arnold","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ejso.2022.06.022_bib10","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1200\/JCO.2017.73.4186","article-title":"Re-evaluating eligibility criteria for Oncology clinical trials: analysis of investigational new drug applications in 2015","volume":"35","author":"Jin","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/CCO.0000000000000470","article-title":"Reappraisal of eligibility criteria in cancer clinical trials","volume":"30","author":"Penel","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1186\/s12885-020-07634-2","article-title":"Impact of prior cancer history on the survival of patients with larynx cancer","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.06.022_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.oraloncology.2015.01.010","article-title":"Effect of previous history of cancer on survival of patients with a second cancer of the head and neck","volume":"51","author":"J\u00e9gu","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ijc.31543","article-title":"Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: a pan-cancer analysis of the SEER database","volume":"143","author":"Zhou","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2022.06.022_bib15","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.2017.74.4102","article-title":"Modernizing clinical trial eligibility criteria: recommendations of the American society of clinical oncology-friends of cancer research organ dysfunction, prior or concurrent malignancy, and comorbidities working group","volume":"35","author":"Lichtman","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib16","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2017.73.7916","article-title":"Broadening eligibility criteria to make clinical trials more representative: American society of clinical Oncology and friends of cancer research Joint research statement","volume":"35","author":"Kim","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib17","first-page":"e53","article-title":"Exclusion of gastrointestinal cancer patients with prior cancer from clinical trials: is this justified?","volume":"15","author":"Smyth","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejso.2022.06.022_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cam4.3722","article-title":"The impact of a prior malignancy on outcomes in gastric cancer patients","volume":"10","author":"Bian","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejso.2022.06.022_bib19","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ejso.2021.02.007","article-title":"Impact of prior cancer history on survival of patients with gastric cancer","volume":"47","author":"Wen","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 23","key":"10.1016\/j.ejso.2022.06.022_bib20","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/cncr.29049","article-title":"The surveillance, Epidemiology, and end results (SEER) program of the national cancer Institute","volume":"120","author":"Cronin","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.06.022_bib21","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","article-title":"The surveillance, Epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship","volume":"40","author":"Duggan","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2022.06.022_bib22","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1038\/s41598-018-24540-7","article-title":"Epidemiology and survival outcomes of mucinous adenocarcinomas: a SEER population-based study","volume":"8","author":"Xie","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2022.06.022_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1186\/s12885-018-4770-2","volume":"18","author":"Slagter","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.06.022_bib25","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.2019.5359","article-title":"Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial","volume":"321","author":"Yu","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2022.06.022_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv002","article-title":"Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual","volume":"107","author":"Laccetti","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2022.06.022_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024798","article-title":"Survival outcomes in esophageal cancer patients with a prior cancer","volume":"100","author":"Pan","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.ejso.2022.06.022_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1186\/s12885-019-6074-6","article-title":"Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria","volume":"19","author":"Al-Husseini","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2022.06.022_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2016.12.024","article-title":"Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma","volume":"144","author":"Pierce","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.06.022_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CEJ.0000000000000540","article-title":"The effect of a gastric second primary cancer on the survival of patients with a previous cancer history","volume":"29","author":"Morais","year":"2020","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ejso.2022.06.022_bib31","article-title":"Secondary oesophageal or gastric cancer in patients treated for head and neck squamous cell carcinoma","volume":"63","author":"Andersen","year":"2016","journal-title":"Dan Med J"},{"key":"10.1016\/j.ejso.2022.06.022_bib32","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.18632\/aging.102984","article-title":"Risk of breast cancer-related death in women with a prior cancer","volume":"12","author":"Ji","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejso.2022.06.022_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000608","article-title":"Impact of prior cancer history on the overall survival of younger patients with lung cancer","volume":"5","author":"Liu","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejso.2022.06.022_bib34","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s10620-019-05917-8","article-title":"Prognosis of hepatocellular carcinoma among cancer survivors with other types of primary tumors","volume":"65","author":"Bian","year":"2020","journal-title":"Dig Dis Sci"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322005248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322005248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:43:27Z","timestamp":1760060607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322005248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0748798322005248"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.06.022","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}